U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 901 - 910 of 1224 results

structurally diverse
Status:
Investigational
Source:
NCT04387760: Phase 2 Interventional Completed SARS-CoV 2
(2020)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT03554109: Phase 2 Interventional Withdrawn Triple Negative Breast Cancer (TNBC)
(2018)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT00397943: Phase 2 Interventional Completed Tuberculosis
(2006)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT04717765: Not Applicable Interventional Completed Oral Mucositis
(2021)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT03554109: Phase 2 Interventional Withdrawn Triple Negative Breast Cancer (TNBC)
(2018)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT03918629: Phase 3 Interventional Completed Clostridium Difficile Associated Disease
(2019)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT03907397: Phase 2 Interventional Completed Food Allergy
(2019)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT03867331: Phase 1 Interventional Completed Malaria,Falciparum
(2019)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT03377296: Not Applicable Interventional Completed Malaria, Vivax
(2018)
Source URL:

Class:
STRUCTURALLY DIVERSE